Maggie L DiNome

17PUBLICATIONS
23CO-AUTHORS
Oncology and carcinogenesis not elsewhere classifiedPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Medical biotechnology diagnostics (incl. biosensors)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Mar 26, 2025
Risk Stratification for Sentinel Lymph Node Positivity in Older Women With Early-Stage Estrogen Receptor-Positive/Human Epidermal Growth Factor Receptor 2 Neu-Negative Invasive Breast Cancer.

Ton Wang, Drew Neish, Samantha M Thomas

|Feb 23, 2024
Racial/Ethnic Disparities in Pathologic Complete Response and Overall Survival in Patients With Triple-Negative Breast Cancer Treated With Neoadjuvant Chemotherapy.

Hannah E Woriax, Samantha M Thomas, Jennifer K Plichta

|Aug 25, 2023
A Pilot Study of Neoadjuvant Nivolumab, Ipilimumab, and Intralesional Oncolytic Virotherapy for HER2-negative Breast Cancer.

Vina P Nguyen, Katie M Campbell, Theodore S Nowicki

|Jul 10, 2023
Construction and validation of a gene expression classifier to predict immunotherapy response in primary triple-negative breast cancer.

Miquel Ensenyat-Mendez, Javier I J Orozco, Pere Llinàs-Arias

|Aug 02, 2022
ASO Author Reflections: Molecular Signatures May Render Surgical Staging of the Axilla Obsolete.

Javier I J Orozco, Julie Le, Jennifer L Baker

|Jul 16, 2022
Machine Learning-Based Epigenetic Classifiers for Axillary Staging of Patients with ER-Positive Early-Stage Breast Cancer.

Javier I J Orozco, Julie Le, Miquel Ensenyat-Mendez

Pageof 3

Frequent Collaborators

2 joint publications

Astrid Botty van den Bruele

2 joint publications

Laura H Rosenberger

2 joint publications

Jennifer K Plichta

1 joint publications

E Shelley Hwang